Yescarta® Now Approved in Japan for Initial Treatment of Relapsed/Refractory Large B-Cell Lymphoma
Yescarta® Now Approved in Japan for Initial Treatment of Relapsed/Refractory Large B-Cell Lymphoma
Source: gilead.com
Page 8 - Rd Division News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rd Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rd Division Today - Breaking & Trending Today
Daiichi Sankyo ENHERTU gets Japanese nod for patients with previously treated HER2 Positive Metastatic Breast Cancer
ENHERTU (trastuzumab deruxtecan, fam-trastuzumab deruxtecan-nxki in the U.S. only) is a HER2 directed ADC.
Source: medicaldialogues.in
Konica Minolta Wins the IEC 1906 Award from the International Electrotechnical Commission for Standardization Activities Related to Light Measurement of Electronic Displays
Konica Minolta Wins the IEC 1906 Award from the International Electrotechnical Commission for Standardization Activities Related to Light Measurement of Electronic Displays.
Source: pressreleasepoint.com
Daiichi Sankyo Company, Limited (DSKYF) Q2 2022 Earnings Call Transcript
Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q2 2022 Results Conference Call October 31, 2022 01:30 AM ET Company Participants Sunao Manabe - Representative Director, President and CEO...
Source: seekingalpha.com
Hyundai Motors' future vehicles to be software-defined by 2025, 2 new EV platforms to be launched
Hyundai Motors plans on introducing two new electric vehicle platforms in the form of eM, a passenger EV-dedicated platform, and eS, an exclusive platform for Purpose Built Vehicles, reports IANS.
Source: india.com